Naylor, Helen M

Helen M Naylor, M.S.

Phone:
(615) 936-3744
Email:
helen.naylor@vumc.org
Office:
3401 West End Ave., Suite 304 M

Job Related Information

Job Title:

  • Senior Research Information Scientist

Department:

Center for Knowledge Management

Area(s) of Responsibility:

  • Filtering/Evidence-Based Services
  • Precision Medicine research and training
  • Translation of Medical and Genetic information for patients
  • Genetic and Health literacy
  • Knowledge Management
  • Education Services
  • Staff Training

Learning Framework Skills:

CV or Resumé

Download

Published Works:

  1. Huang JK, Wen L, Swegle M, Tran HC, Thin TH, Naylor HM, et al. Nucleotide sequence of a rice genomic clone that encodes a class I endochitinase. Plant molecular biology. 1991;16(3):479-80. Epub 1991/03/01.  [Full-text in PubMed PMID:  1893114]

 

  1. Naylor HM, Newcomer ME. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry. 1999;38(9):2647-53. Epub 1999/03/03.  [Full-text in PubMed PMID:  10052934]

 

  1. Giuse NB, Kusnoor SV, Koonce TY, Ryland CR, Walden RR, Naylor HM, et al. Strategically aligning a mandala of competencies to advance a transformative vision. Journal of the Medical Library Association: JMLA. 2013;101(4):261.  [Full-text in PubMed PMID:  24163597]

 

  1. Choma DP, Vanacore R, Naylor H, Zimmerman IA, Pavlichenko A, Pavlichenko A, et al. Aquaporin 11 Variant Associates with Kidney Disease in Type 2 Diabetic Patients. American journal of physiology Renal physiology. 2015:ajprenal 00295 2015.  [Full-text in PubMed PMID:  26719361]

 

  1. Giuse NB, Kusnoor SV, Koonce TY, Naylor HM, Chen SC, Blasingame MN, et al. Guiding Oncology Patients Through the Maze of Precision Medicine. Journal of health communication. 2016;21 Suppl:5-17.  [Full-text in PubMed PMID:  27043753]

 

  1. Pulley, JM, Jerome, RN, Zaleski, NM, Shirey-Rice, JK, Pruijssers, AJ, Lavieri, RR, Chettiar, SN, Naylor, HN, Arnoff, DM, Edwards, DA, Niswender, CM, Dugan, LL, Crofford, LJ, Bernard, GR  Holroyd, KJ.  When Enough is Enough: Decision Criteria for Moving a Known Drug Into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.  Submitted to ASSAY and Drug Development. Technologies, September 29, 2017; Accepted for publication November 3, 2017.